TY  - JOUR

T1  - Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

JO  - The Lancet Infectious Diseases

UR  - https://eprints.whiterose.ac.uk/id/eprint/227359

PY  - 2025/05/15

AU  - Abani O

AU  - Abbas A

AU  - Abbas F

AU  - Abbas J

AU  - Abbas K

AU  - Abbas M

AU  - Abbasi S

AU  - Abbass H

AU  - Abbott A

AU  - Abdallah N

AU  - Abdelaziz A et al

ED  - 

DO  - DOI: 10.1016/s1473-3099(25)00093-3

PB  - Elsevier BV

Y2  - 2025/06/09

ER  -